ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

NCT00658788 ·Status: COMPLETED ·Phase: PHASE3

To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis

NCT00747032 ·Status: WITHDRAWN ·Phase: PHASE3

A Study of R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

NCT00504270 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study

NCT06648772 ·Status: RECRUITING ·Phase: PHASE3

Efficacy, Tolerance and Satisfaction With CLOBEX® Spray When Used as Monotherapy or Add-on Therapy in Plaque Psoriasis

NCT00437216 ·Status: COMPLETED

Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis

NCT04211363 ·Status: COMPLETED ·Phase: PHASE3

Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis

NCT00617994 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety, Preference and Response Duration of Clobex® Spray and Taclonex® Ointment in Psoriasis

NCT00437255 ·Status: COMPLETED ·Phase: PHASE4

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

NCT00733954 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

NCT06723171 ·Status: SUSPENDED ·Phase: PHASE2

Assessment for Tachyphylaxis to Topical Corticosteroids in the Treatment of Psoriasis

NCT01404338 ·Status: COMPLETED ·Phase: PHASE1

Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients

NCT01936337 ·Status: COMPLETED ·Phase: PHASE2

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis

NCT00715975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris

NCT01595997 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis

NCT00778700 ·Status: COMPLETED ·Phase: PHASE2

Anti-Inflammatory Effects of 0.045% Tazarotene/0.01% Halobetasol Lotion in Psoriasis

NCT06042647 ·Status: COMPLETED ·Phase: PHASE4

Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%

NCT01893567 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis

NCT01194219 ·Status: COMPLETED ·Phase: PHASE3

Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis

NCT03431974 ·Status: COMPLETED ·Phase: PHASE2

Luma Light System Proof of Concept Study in Subjects With Mild to Moderate Psoriasis

NCT02447068 ·Status: UNKNOWN ·Phase: NA

A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris

NCT01043224 ·Status: COMPLETED ·Phase: PHASE1

Apremilast in Combination With Clobetasol Spray for the Treatment of Plaque Psoriasis

NCT03453190 ·Status: UNKNOWN ·Phase: PHASE4

Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis

NCT03764475 ·Status: COMPLETED ·Phase: PHASE2

A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris

NCT01347255 ·Status: COMPLETED ·Phase: PHASE2

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

NCT00436540 ·Status: COMPLETED ·Phase: PHASE4